Fresh Tracks wants CEO to lead dissolution

Embattled drug maker Fresh Tracks Therapeutics Inc. (OTC: FRTX) has asked a Delaware judge to allow its CEO to serve as the company’s custodian as it attempts to dissolve its business operations.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Already have a paid subscription?